Clinical Trial Update: Combination Immunotherapy in Biochemically Recurrent Prostate Cancer [Phase 2]

View source ↗

Summary

This clinical trial update reports results from a Phase 2 trial of a combination immunotherapy for biochemically recurrent prostate cancer. Results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-06-19